Разработана вакцина против covid-19


International application PCT/RU2014/000096, priority 15.02.13

Patents for invention

Patent applications for inventions:

  • Mexico No. 2015010623, the filing date 17.08.2015,
  • Thailand No. 1501004605, the filing date 14.08.2015,
  • Nicaragua No. 2015-00109, the filing date 14.08.2015,
  • Vietnam’s No. 1-2015-03347, the filing date 11.09.2015.

A universal vaccine capable of providing protection against existing and possible reassortant strains of influenza virus has been created.

After inoculation with the vaccine, a person develops immunity to various subtypes of influenza viruses A and B, existing, as well as those that may appear as a result of reassortment of any strains of influenza viruses.

The vaccine is safe due to the active substance-recombinant protein, which avoids the risks associated with the introduction of a virus into the body, albeit inactivated.

Assessment of the significance of this development